Qvents
Discussion forum for Pharma Quality events, Regulatory Actions
FDA withdraws approval Oxandrin (Oxandrolone), Gemini Laboratories’ anabolic steroid indicated for weight gain after extensive surgery, relief of bone pain due to osteoporosis as there was no evidence of efficacy for the tablets and potential problems with the drug are sufficiently serious Read More..
Home
News
FDA withdraws approval Oxandrin (Oxandrolone), Gemini Laboratories’ anabolic steroid indicated for weight gain after extensive surgery, relief of bone pain due to osteoporosis as there was no evidence of efficacy for the tablets and potential problems with the drug are sufficiently serious <a href="https://www.federalregister.gov/documents/2023/06/28/2023-13733/gemini-laboratories-llc-et-al-withdrawal-of-approval-of-one-new-drug-application-for-oxandrin" target="_blank" rel="noopener">Read More..</a>
Home
News
FDA withdraws approval Oxandrin (Oxandrolone), Gemini Laboratories’ anabolic steroid indicated for weight gain after extensive surgery, relief of bone pain due to osteoporosis as there was no evidence of efficacy for the tablets and potential problems with the drug are sufficiently serious <a href="https://www.federalregister.gov/documents/2023/06/28/2023-13733/gemini-laboratories-llc-et-al-withdrawal-of-approval-of-one-new-drug-application-for-oxandrin" target="_blank" rel="noopener">Read More..</a>
No links available.
Leave a Comment
You must be logged in to post a comment.